prikaz prve stranice dokumenta Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
  Preuzmi
PDF 452.67 KB
Stručni rad - Stručni rad
Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
Pharmacological Research, 158 (2020); 104891. https://doi.org/10.1016/j.phrs.2020.104891
Banach, Maciej; Penson, Peter E.; Fras, Zlatko; Vrablik, Michal; Pella, Daniel; Reiner, Željko; Nabavi, Seyed Mohammad; Sahebkar, Amirhossein; Kayikcioglu, Meral; Daccord, Magdalena

Povezani objekti
COVID-19 | Virtualna zbirka
Citirajte ovaj rad

Banach, M., Penson, P. E., Fras, Z., Vrablik, M., Pella, D., Reiner, Ž. ... Daccord, M. (2020). Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacological Research, 158.. doi: 10.1016/j.phrs.2020.104891

Banach, Maciej, et al. "Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic." Pharmacological Research, vol. 158, 2020. https://doi.org/10.1016/j.phrs.2020.104891

Banach, Maciej, Peter E. Penson, Zlatko Fras, Michal Vrablik, Daniel Pella, Željko Reiner, Seyed Mohammad Nabavi, Amirhossein Sahebkar, Meral Kayikcioglu i Magdalena Daccord. "Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic." Pharmacological Research 158 (2020). https://doi.org/10.1016/j.phrs.2020.104891

Banach, M., et al. (2020) 'Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic', Pharmacological Research, 158. doi: 10.1016/j.phrs.2020.104891

Banach M, Penson PE, Fras Z, Vrablik M, Pella D, Reiner Ž, i sur.. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacological Research [Internet]. 08.2020. [pristupljeno 14.04.2024.];158. doi: 10.1016/j.phrs.2020.104891

M. Banach, et al., "Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic", Pharmacological Research, vol. 158, Kolovoz 2020. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:602195. [Citirano: 14.04.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:602195
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
AutorMaciej Banach
AutorPeter E. Penson
AutorZlatko Fras
AutorMichal Vrablik
AutorDaniel Pella
AutorŽeljko Reiner
AutorSeyed Mohammad Nabavi
AutorAmirhossein Sahebkar
AutorMeral Kayikcioglu
AutorMagdalena Daccord
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Individuals with Familial Hypercholesterolaemia (FH) are at very high risk of cardiovascular disease, which is associated with poor outcomes from coronavirus infections. COVID-19 puts strain on healthcare systems and may impair access to routine FH services. On behalf of the International Lipid Expert Panel (ILEP) and the European FH Patient Network (FH Europe), we present brief recommendations on the management of adult patients with FH during the COVID-19 pandemic. We discuss the implications of COVID-19 infections for FH patients, the importance of continuing lipid-lowering therapy where possible, issues relating to safety monitoring and service delivery. We summarise the evidence for additional benefits of statins and other lipid-lowering drugs during viral infections. The recommendations do not override in any way the individual responsibility of physicians to make appropriate and accurate decisions taking into account the condition of a given patient and the doses, rules, and regulations applicable to drugs and devices at the time of their prescription/use.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeStručni rad - Stručni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaPharmacological Research
Brojčani podacivol. 158, 104891
p-ISSN1043-6618
e-ISSN1096-1186
DOIhttps://doi.org/10.1016/j.phrs.2020.104891
URN:NBNurn:nbn:hr:105:602195
Datum objave publikacije2020-08
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S1043661820311993
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2021-05-24 08:50:11